Humana SG&A Expenses 2012-2026 | HUM | MacroTrends

Humana SG&A Expenses 2012-2026 | HUM

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Humana sg&a expenses for the twelve months ending March 31, 2026 were $0M, a 0% increase year-over-year.

Humana annual sg&a expenses for 2025 were $0B, a 0% decline from 2024.
Humana annual sg&a expenses for 2024 were $0B, a 0% decline from 2023.
Humana annual sg&a expenses for 2023 were $0B, a 0% decline from 2022.

Humana SG&A Expenses 2012-2026 | HUM

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Humana annual sg&a expenses for 2025 were $0B, a 0% decline from 2024.
Humana annual sg&a expenses for 2024 were $0B, a 0% decline from 2023.
Humana annual sg&a expenses for 2023 were $0B, a 0% decline from 2022.

Related Stocks
Company Name	Market Cap
UnitedHealth Group (UNH)	$276.2B
Cigna Group (CI)	$71.5B
Centene (CNC)	$18.3B
Molina Healthcare (MOH)	$7.6B
Select Medical Holdings (SEM)	$2B
Joint (JYNT)	$125M
Aethlon Medical (AEMD)	$3M